Australia, May 13 -- GEROSYNTH LABORATORIES Inc., owns the trademark (2626910) for 'MEBETULENE' till Nov. 13, 2035.
Status: protected:
Registered/protected
Classes: 1 [Active chemical ingredients for use in the manufacture of anti-cancer drugs.] and 5 [Biological preparations for the treatment of cancer; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer.]
Type of Mark: Word
Date of Acceptance: March 5
Registration Advertised: May 12
For further details contact Greg Gronholm GRONHOLM PATENT SERVICES.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2626910.
Disclaimer: Curated by HT Syndication.
